Clinical trials specialist MeDiNova has appointed Julie Gray as its new Regional Site Director for the Southern region as part of its strategic growth plans.
In her new role she will manage the company’s three Dedicated Research Centres in the London area, at Northwood, Romford and Sidcup.
Her responsibilities will include ensuring patients have a good experience during clinical trials and that patients are brought into studies in a timely manner. She is also responsible for maintaining a good balance of clinical trials at the sites.
Gray comes to MeDiNova with extensive experience gained in the NHS and a leading research company, where she was a Site Director. When with the NHS she was responsible for a number of initiatives, working with surgeons and consultants, including the creation of a research centre of excellence in (Wrightington, Wigan and Leigh NHS Trust).
Gray said: “I am delighted to be joining MeDiNova at this exciting time of expansion and look forward to helping to grow the company by welcoming more patients through our doors.”
“MeDiNova puts patients at the heart of its operations and is a forward-thinking company that offers a host of opportunities.”
Kumar Muthalagappan, Chief Executive at MeDiNova, said: “We are delighted to welcome Julie Gray to our team. She shares MeDiNova’s commitment to excellence and providing first-class care for patients.”
MeDiNova is positioned to be the leading global site management organisation in terms of quality, recruitment and delivery. The company has global reach and operates 36 sites across four countries — Spain, South Africa, the US and the UK, conducting studies into potential treatments for a variety of conditions including osteoarthritis, asthma, chronic obstructive pulmonary disease, diabetes, arthritis and vaccine studies.
